Free Trial
NYSE:GBS

GBS (GBS) Stock Price, News & Analysis

GBS logo
$1.48 +0.07 (+4.96%)
As of 05/28/2025

About GBS Stock (NYSE:GBS)

Key Stats

Today's Range
$1.41
$1.57
50-Day Range
$1.15
$2.16
52-Week Range
$0.36
$2.89
Volume
143,311 shs
Average Volume
955,325 shs
Market Capitalization
$22.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Receive GBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter.

GBS Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Yadu marks his debut with Kuntebille
See More Headlines

GBS Stock Analysis - Frequently Asked Questions

GBS's stock was trading at $1.40 on January 1st, 2025. Since then, GBS stock has increased by 5.7% and is now trading at $1.48.
View the best growth stocks for 2025 here
.

GBS Inc. (NYSE:GBS) released its quarterly earnings results on Wednesday, August, 31st. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.04.

Shares of GBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GBS investors own include Athenex (ATNX), Biora Therapeutics (BIOR), Citius Pharmaceuticals (CTXR), KLX Energy Services (KLXE), BSQUARE (BSQR), Communications Systems (JCS) and Meta Platforms (META).

Company Calendar

Last Earnings
8/31/2022
Today
5/29/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSE:GBS
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.31 million
Pretax Margin
-1,907.09%

Debt

Sales & Book Value

Annual Sales
$440,000.00
Price / Cash Flow
N/A
Book Value
$0.44 per share
Price / Book
3.20

Miscellaneous

Free Float
14,850,000
Market Cap
$20.99 million
Optionable
Not Optionable
Beta
1.32
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NYSE:GBS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners